/ About this event
Biotech companies face a unique challenge: investors expect startup speed, while science demands precision.
From the moment a company raises its first institutional round, founders are balancing competing priorities—building a team, managing burn, accelerating R&D, raising the next round, navigating regulatory milestones, and maintaining scientific integrity under increasing pressure.
This session brings together founders, investors, operators, and people leaders to discuss what it actually takes to scale a biotechnology company responsibly. Rather than focusing solely on fundraising, the conversation explores the operational decisions that determine whether companies can sustain growth while continuing to deliver rigorous science, attract exceptional talent, and build organizations that last.
This event is a part of #SFTechWeek—a week of events hosted by VCs and startups to bring together the tech ecosystem. Learn more at www.tech-week.com.
